VYNE
NASDAQ
$0.81
VYNE Therapeutics Inc (VYNE)
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapies for dermatology. The company is headquartered in Bridgewater, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Hold
Target: $2 (+147.59%)
Market Cap
$25M
P/B Ratio
0.96
Beta (5Y)
1.13
Price Chart
Valuation
Market Cap$25M
P/S55.68
P/B0.96
Profitability
Total Revenue (TTM)$441K
Gross Profit (TTM)$454K
EBITDA-$34M
Operating Margin-4437%
EPS-$1.75
Growth & Risk
EPS 5Y CAGR-49.07%
Revenue 5Y CAGR-51.74%
FCF 5Y CAGR-22.72%
Beta (5Y)1.13
Sharpe Ratio0.36